Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Feb 9;27(8):1168–1176. doi: 10.1200/JCO.2008.18.1024

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2009 by American Society of Clinical Oncology

PMC Copyright notice

Fig 1. — Disease-free and overall survival among patients according to biologic subtype. (A) Disease-free survival and (B) overall survival for patients stratified into triple-negative (estrogen receptor [ER] negative, progesterone receptor [PR] negative, HER2/neu [HER2] negative), HER2 (HER2-positive, ER-negative, PR-negative), luminal B (LB; ER-positive or PR-positive and either HER2-positive or Ki67^high) and luminal A (LA; ER-positive or PR-positive and not HER2-positive or Ki67^high) groups. Pairwise comparisons between subtypes were statistically significant (see text).